Gilead Sciences to Present at the UBS Global Healthcare Conference on Monday, May 23
May 20 2016 - 5:00PM
Business Wire
Webcast Available Through Gilead Corporate
Website
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its
corporate presentation will be webcast from the UBS Global
Healthcare Conference in New York.
Norbert W. Bischofberger, Gilead’s Executive Vice President,
R&D and Chief Scientific Officer, will provide an overview of
the company at the conference on Monday, May 23 at 9:30 a.m.
Eastern Time.
The live webcast can be accessed at the company’s Investors page
at www.gilead.com/investors. Please connect to the company’s
website at least 15 minutes prior to the start of the presentation
to ensure adequate time for any software download that may be
required to listen to the webcast. The replay will be available for
14 days following the presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases. Gilead has
operations in more than 30 countries worldwide, with headquarters
in Foster City, California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160520005701/en/
Gilead Sciences, Inc.Sung Lee, 650-524-7792Investor
Relations
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024